Sera Increases Series B Round to $25M with $5M from Gates Foundation | GenomeWeb

NEW YORK (GenomeWeb) – Sera Prognostics said today that it has increased its Series B financing round with a $5 million investment by the Bill & Melinda Gates Foundation.

The investment brings total funding in the round to $25 million. Sera originally announced the closing of the round last month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.